21 CFR 862.1705
§ 862.1705 Triglyceride test system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 862.1705, § 862.1705 Triglyceride test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89191
- Permanent ID
ys:prov:89191@1- SHA-256
1b11bd2a138e25ca57eb03c4feb64432421ef8c571b2ed22d5b0fc2a0e0e949c
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A triglyceride test system is a device intended to measure triglyceride (neutral fat) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid metabolism, or various endocrine disorders.
(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.